These studies, which may not recapitulate the complex biology involved in atherosclerosis development and progression in vivo, nevertheless demonstrate that exposure to the curcumin derivative EF24 exerts promising anti-atherosclerotic effects by reversing some of the above deleterious effects of IL-18 in this cell type. This evidence concerns the gene IL18 and atherosclerosis.